[Vidarabine-interferon combination in patients with chronic viral hepatitis B of mutant form. Efficiency and tolerability during a pilot study]

Presse Med. 1996 Mar 16;25(9):459.
[Article in French]
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Hepatitis B / drug therapy*
  • Hepatitis B / virology
  • Hepatitis, Chronic / drug therapy
  • Hepatitis, Chronic / virology
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Middle Aged
  • Pilot Projects
  • Recombinant Proteins
  • Vidarabine / therapeutic use*

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Vidarabine